Hippocampal age-related changes in schizophrenia: A proton magnetic resonance spectroscopy study

Schizophrenia Research

Volumn 22, Issue 1, 1996, Pages 5-17

  Maier, M ^a   Ron, M A ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

hippocampus; proton magnetic resonance spectroscopy; schizophrenia

Indexed keywords

CHOLINE; CREATINE; N ACETYLASPARTIC ACID;

ADULT; AGE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HIPPOCAMPUS; HUMAN; MALE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SCHIZOPHRENIA;

EID: 0030592469     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/0920-9964(96)00044-8     Document Type: Article

References (83)

1. Altshuler, .L.L (1987) Hippocampal pyramidal cell orientation in schizophrenia. Arch. Gen. Psychiatry 44, 1094-1098.
2. Arnold, D.L. (1992) Reversible reduction of NAA after acute central nervous system damage. Soc. Magn. Reson. Med. (Book of Abstracts) 1, 643.
3. Arnold, D.L., Mathews, P.M., Francis, G. and Antel, J. (1990) Proton magnetic resonance spectroscopy of human brain in vivo in the evaluation of multiple sclerosis: assessment of the load of the disease. Magn. Reson. Med. 14, 154-159.
4. 1H-NMR spectroscopy in Canavan's Disease: A report of two cases. Magn. Reson. Med. 19, 439-445.
5. Benes, F.M., Turtle, M., Khan, Y. and Farol, P. (1994) Myelination of a key zone in the hippocampal formation occurs in the human brain during childhood, adolescence and adulthood. Arch. Gen. Psychiatry 51, 477-484.
6. Bilder, R.M., Lipschutz-Broch, L., Reiter, G., Geisler, S.H., Mayerhoff, D.I. and Lieberman, J.A. (1991) Neuropsychological deficits early in the course of first episode schizophrenia. Schizophr. Res. 5, 198-199.
7. 1H-NMR spectroscopic studies of brain. Neurosci. Biobehav. Rev. 13, 23-31.
8. Bogerts, B., Ashtari, M., DeGreef, G., Alvir, J.-M.S., Bilder, R.M. and Lieberman, J.A. (1990) Reduced temporal limbic structure volumes on magnetic resonance images in first episode schizophrenia. Psychiatry Res. 35, 1-13.
9. Breiter, S.N., Arroyo, S., Mathews, V.P., Lesser, R.P., Bryan, R.N. and Barker, P.B. (1994) Proton MR spectroscopy in patients with seizure disorders. Am. J. Neuroradiol. 15, 373-384.
10. Brenner, R.E., Beech, J.S., Williams, S.C.R., Bell, J.D. and McDonald, W.I. (1993) Reversibility of the reduction of NAA in diabetic ketoacidosis. Soc. Magn. Reson. Med. (Book of Abstracts) 3, 1559.
11. Brown, R., Colter, N., Corsellis, J.A.N., Crow, T.J., Frith, C.D., Jagoe, R., Johnstone, E.C. and Marsh, L. (1986) Postmortem evidence of structural brain changes in schizophrenia. Arch. Gen. Psychiatry 43, 36-42.
12. Bruhn, H., Frahm, J., Gyngell, M.L., Merboldt, K.D., Haenicke, W. and Sauter, R. (1989) Cerebral metabolism in man after acute stroke: new observations using localized proton NMR spectroscopy. Magn. Reson. Med. 9, 126-131.
13. Bruhn, H., Weber, T., Thorwirth, V. Frahm, J. (1991) In vivo monitoring of neuronal loss in Creutzfeldt-Jakob disease by proton magnetic resonance spectroscopy. Lancet 337, 1610-1611.
14. Bruton, C.J., Crow, T.J., Frith, C.D., Johnstone, E.C., Owens, D.G.C. and Roberts, G.W. (1990) Schizophrenia and the brain: a prospective clinico-neuropathological study. Psychol. Med. 20, 285-304.
15. Bruton, C.J., Stevens, J. and Frith, C.D. (1994) Epilepsy, psychosis, and schizophrenia: Clinical and neuropathological considerations. Neurology 44, 34-42.
16. Chong, W.K., Sweeney, B., Wilkinson, I.D., Paley, M., Hall-Craggs, M.A., Kendall, B.E., Shepard, J.K., Beecham, M., Miller, R.F., Weller, I.V.D., Newman, S.P. and Harrison, M.J. (1993) Proton spectroscopy of the brain in HIV infection: correlation with clinical immunologic and MR imaging findings. Radiology 188, 119-124.
17. Christiansen, P., Toft, P., Larsson, H.B.W., Stubgaard, M. and Henriksen, O. (1993) The concentration of N-acetyl aspartate, creatine+phosphocreatine, and choline in different parts of the brain in adulthood and senium. Magn. Reson. Imaging 11, 799-806.
18. Chua, S.E. and McKenna, P.J. (1995) Schizophrenia - a brain disease? A critical review of structural and functional cerebral abnormality in the disorder. Br. J. Psychiatry 166, 563-582.
19. Conrad, A.J., Abebe, T., Austin, R., Forsythe, S. and Scheibel, A.B. (1991) Hippocampal pyramidal cell disarray in schizophrenia as a bilateral phenomenon. Arch. Gen. Psychiatry 48, 413-417.
20. Crow, T.J. and Stevens, M. (1978) Age disorientation in chronic schizophrenia: The nature of the cognitive deficit. Br. J. Psychiatry 133, 137.
21. Davidson, M., Powchik, V., Haroutunian, V., Harvey, P.D., Perl, D., Losonczy, M.S., Freske, E., Bierer, L., Mohs, R.C. and Davis, K.L. (1991) Dementia-like symptoms in elderly schizophrenic patients. In: Program and abstracts of the 30th Annual Meeting of the American College of Neuropsychopharmacology; December 9-13, 1991; San Juan, Puerto Rico, p. 67.
22. Davie, C.A., Hawkins, C.P., Barker, G.J., Brennan, A., Tofts, P.S., Miller, D.H. and McDonald, W.I. (1994) Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions. Brain 117, 49-58.
23. DeCarli, C., Murphy, D.G.M., Gillette, J.A., Haxby, J.V., Teichberg, D., Schapiro, M.B. and Horwitz, B. (1994) Lack of age-related differences in temporal lobe volumes of very healthy adults. Am. J. Neuroradiol. 15, 689-696.
24. DeGreef, G., Ashtari, M., Wu, H., Borenstein, M., Geisler, S. and Lieberman, J. (1991) Follow-up MRI study in first episode schizophrenia. Schizophr. Res. 5, 204-205.
25. DeLisi, L.E., Tew, W., Xie, S., Hoff, A.L., Sakuma, M., Kushner, M., Lee, G., Shedlack, K., Smith, A.M. and Grimson, R. (1995) A prospective follow-up study of brain morphology and cognition in first-episode schizophrenic patients: Preliminary findings. Biol. Psychiatry 38, 349-360.
26. Demisch, L., Gerbaldo, H., Heinz, K. and Kirsten, R. (1987) Transmembranal signalling in schizophrenic and affective disorders: Studies on arachidonic acid and phospholipids. Schizophr. Res. 2, 275-282.
27. De Stefano, N., Francis, G., Antel, J.P. and Arnold, D.L. (1993) Reversible decrease of NAA in the brain of patients with relapsing remitting multiple sclerosis. Soc. Magn. Reson. Med. (Book of Abstracts) 1, 280.
28. Espanol, M.T., Yang, G.Y., Shimizu, H., Xu, Y., Chang, L.H., Weinstein, P., Litt, L. and James, T.L. (1992) Does NAA predict outcome of transient global cerebral ischaemia in rat brain? Soc. Magn. Reson. Med. (Book of Abstracts) 2, 2148.
29. Falkai, P. and Bogerts, B. (1993) Brain development and schizophrenia. In: Kerwin RW (ed) Neurobiology and Psychiatry, vol 2. Cambridge University Press, Cambridge, pp. 43-70.
30. Falkai, P. and Bogerts, B. (1986) Cell loss in the hippocampus of schizophrenics. Eur. Arch. Psychiatry Clin. Neurosci. 236, 154-161.
31. Fish, B., Marcus, J., Hans, S.L., Auerbach, J.G. and Perdue, S. (1992) Infants at risk for schizophrenia: Sequelae of a genetic neurointegrative defect: A review and replication analysis of pandysmaturation in the Jerusalem infant development study. Arch. Gen. Psychiatry 49, 221-235.
32. Fisher, M., Sotak, C.H., Minematsu, K. and Li, L. (1992) New magnetic resonance techniques for evaluating cerebrovascular disease. Ann. Neurol. 32, 115-122.
33. Fisman, M. (1975) The brain stem in psychosis. Br. J. Psychiatry 126, 414-422.
34. Frahm, J., Bruhn, H., Gyngell, M.L., Merboldt, K.D., Hanicke, W. and Sauter, R. (1989a) Localized high-resolution proton NMR spectroscopy using stimulated echoes: initial applications to human brain in vivo. Magn. Reson. Med. 9, 79-93.
35. Frahm, J., Bruhn, H., Gyngell, M.L., Merboldt, K.D., Haenicke, W. and Sauter, R. (1989b) Localised proton NMR spectroscopy in different regions of the human brain in vivo. Relaxation times and concentrations of cerebral metabolites. Magn. Reson. Med. 11, 47-63.
36. Gattaz, W.F., Kolisch, M., Thuren, T., Virtanen, J.A. and Kinnunen, P.K.J. (1987) Increased plasma phospholipase A2 activity in schizophrenic patients: Reduction after neuroleptic therapy. Biol. Psychiatry 22, 421-426.
37. Gill, S.S., Thomas, D.G.T., Van Bruggen, N., Gadian, D.G., Peden, C.J., Bell, J.D., Cox, J., Menon, D.K., Iles, R.A., Bryant, D.J. and Coutts, G.A. (1990) Proton MR spectroscopy of intracranial tumours: in vivo and in vitro studies. J. Comput. Assist. Tomogr. 14, 497-504.
38. Ginobili de Martinez, M.S., Rodrigues de Turco, E.B. and Barrantes, F.J. (1985) Endogenous asymmetry of rat brain lipids and dominance of the right cerebral hemisphere in free fatty acid response to electroconvulsive shock. Brain Res. 339, 315-322.
39. Ginobili de Martinez, M.S., Rodrigues de Turco, E.B. and Barrantes, F.J. (1986) Asymmetry of diacylglycerol metabolism in rat brain hemispheres. J. Neurochem. 46, 1382-1386.
40. Goldberg, T.E., Karson, C.N., Leleszi, J.P. and Weinberger, D.R. (1988) Intellectual impairment of adolescent psychosis: A controlled psychometric study. Schizophr. Res. 1, 261-266.
41. Goldberg, T.E., Hyde, T.M., Kleinman, J.E. and Weinberger, D.R. (1993) Course of schizophrenia: Neuropsychological evidence for a static encephalopathy. Schizophr. Bull. 19, 797-804.
42. Graham, S.H., Meyerhoff, D.J., Bayne, L., Sharp, F.R. and Weiner, M.W. (1994) Magnetic resonance spectroscopy of N-acetyl aspartate in hypoxic-ischaemic encephalopathy. Ann. Neurol. 35, 490-494.
43. Grodd, W., Kraegelch-Mann, I., Peterson, D., Trefz, F.K. and Harzer, K. (1990) In vivo assessment of N-acetyl aspartate in brain in spongy degeneration (Canavan's disease) by proton spectroscopy. Lancet 336, 437-438.
44. Harrison, P.J. (1995) On the neuropathology of schizophrenia and its dementia: neurodevelopmental, neurodegenerative, or both? Neurodegeneration 4, 1-12.
45. Heaton, R., Paulsen, J.S., McAdams, L.A., Kuck, J., Zisook, S., Braff, D., Harris, M.J. and Jeste, D.V. (1994) Neuropsychological deficits in schizophrenia. Arch. Gen. Psychiatry 51, 469-476.
46. Heckers, S., Heinsen, H., Geiger, B. Beckmann, H. (1991) Hippocampal neuron number in schizophrenia. Arch. Gen. Psychiatry 48, 1002-1008.
47. Hitzmann, R., Hirschowitz, D. and Garver, D. (1984) Membrane abnormalities in the psychoses and affective disorders. J. Psychiatr. Res. 18, 319-326.
48. Hoff, A.L., Riordan, H., O'Donnell, D.W. and DeLisi, L.E. (1991) Cross-sectional and longitudinal neuropsychological test findings in first episode schizophrenic patients. Schizophr. Res. 5, 197-198.
49. Horrobin, D.F., Glen, A.I.M. and Krishna Vaddadi (1994) The membrane hypothesis of schizophrenia. Schizophr. Res. 13, 195-207.
50. Illowsky, B.P., Juliano, D.M., Bigelow, L.B. and Weinberger, D.R. (1988) Stability of CT scan findings in schizophrenia: Results of an eight year follow-up study. J. Neurol. Neurosurg. Psychiatry 51, 209-213.
51. Jaskiw, G.E., Juliano, D.M., Goldberg, T.E., Hertzman, M., Urow-Hamell, E., Weinberger, D.R. (1994) Cerebral ventricular enlargement in schizophreniform disorder does not progress. A seven year follow-up study. Schizophr. Res. 14, 23-28.
52. Kingsley, L. and Struening, E.L. (1966) Changes in intellectual performance of acute and chronic schizophrenics. Psychol. Rep. 18, 791-800.
53. Koller, K.J., Zaczek, R. and Coyle, J.T. (1984) N-Acetyl-aspartyl-glutamate: regional levels in rat brain and the effects of brain lesions as determined by a new HPLC method. J. Neurochem. 43, 1136-1142.
54. Maier, M., Ron, M.A., Barker, G.J. and Tofts, P.S. (1995) Proton magnetic resonance spectroscopy: An in vivo method of estimating hippocampal neuronal depletion in schizophrenia. Psychol. Med. 25, 1201-1209.
55. Marsh, L., Suddath, R.L., Higgins, N. and Weinberger, D.R. (1994) Medial temporal lobe structures in schizophrenia: Relationship of size to duration of illness. Schizophr. Res. 11, 225-238.
56. 1H-NMR spectroscopy: N-acetyl-aspartate, creatine and choline. NMR Biomed. 4, 47-52.
57. Miller, D.H., Austin, S.J., Connelly, A., Youl, B.D., Gadian, D.G. and McDonald, W.I. (1991) Proton magnetic resonance spectroscopy of an acute and chronic lesion in multiple sclerosis. Lancet 337, 58-59.
58. Miller, R. (1989) Schizophrenia as a progressive disorder: relations to EEG, CT, neuropathological and other evidence. Prog. Neurobiol. 33, 77-85.
59. Nasrallah, H.A., Olson, S.C., McCalley-Whitters, M., Chapman, S. and Jacoby, C.G. (1986) General ventricular enlargement in schizophrenia: A preliminary follow-up study. Arch. Gen. Psychiatry 43, 157-159.
60. 1H-MRS) of the hippocampal formation in schizophrenia: a pilot study. Br. J. Psychiatry 165, 481-485.
61. Nieto, D. and Escobar, A. (1972) Major psychoses. In: Minkler, J. (Ed.), Pathology of the Nervous System, Vol. 3. McGraw-Hill, New York, NY, pp. 2654-2665.
62. Nopoulos, P., Flashman, L., Flaum, M., Arndt, S. and Andreasen, N. (1994) Stability of cognitive functioning early in the course of schizophrenia. Schizophr. Res. 14, 29-37.
63. O'Callaghan, E., Buckley, P., Redmond, O., Stack, J., Ennis, J.T., Larkin, C. and Waddington, J.L. (1992) Abnormalities of cerebral structure in schizophrenia on magnetic resonance imaging: interpretation in relation to the neurodevelopmental hypothesis. J. R. Soc. Med. 85, 227-231.
64. Okomura, N., Otsuki, S. and Nasu, H. (1959) The influence of insulin hypoglycaemic coma, repeated electroshocks, and chlorpromazine or beta-phenylisopropylmethylamine administration on the free amino acids in the brain. J. Biochem. 46, 247-252.
65. Pangerl, A.M., Steudle, A., Jaroni, H.W., Rufer, R. and Gattz, W.F. (1991) Increased platelet membrane lysophosphatidylcholine in schizophrenia. Biol. Psychiatry 8, 837-840.
66. 31P nuclear magnetic resonance (NMR) spectroscopy of brain in aging and Alzheimer's disease. J. Neural Transm. Suppl. 24, 261-268.
67. Pettegrew, J.W., Keshavan, M.S., Panchalingam, K., Strychor, S., Kaplan, D.B., Tretta, M.G. and Allen, M. (1991) Alterations in brain high energy phosphate and membrane phospholipid metabolism in first episode, drug naive schizophrenics: A pilot study of dorsal prefrontal cortex by in vivo phosphorous 31 nuclear magnetic resonance spectroscopy. Arch. Gen. Psychiatry 48, 563-568.
68. Roberts, G.W. (1991) Schizophrenia: A neuropathological perspective. Br. J. Psychiatry 158, 8-17.
69. Scheibel, A.B. and Conrad, A.S. (1993) Hippocampal dysgenesis in mutant mouse and schizophrenic man: is there a relationship? Schizophr. Bull. 19, 21-33.
70. Schwarzkopf, S.B., Olson, S.C., Coffman, J.A. and Nasrallah, H.A. (1990) Third and lateral ventricular volumes in schizophrenia: support for progressive enlargement of both structures. Psychopharmacol. Bull. 26, 385-391.
71. Schwartzman, A.E. and Douglas, V.I. (1962) Intellectual loss in schizophrenia: Part II. Can. J. Psychol. 16, 161-168.
72. Steudle, A., Maras, A. and Gattaz, W.F. (1994) Platelet membrane phospholipids in schizophrenia. Schizophr. Res. 11, 123.
73. Stevens, J.D. (1972) The distribution of phospholipid fractions in the red cell membranes of schizophrenics. Schizophr. Bull. 6, 60-61.
74. Stevens, J.R. (1982) Neuropathology of schizophrenia. Arch. Gen. Psychiatry 39, 1131-1139.
75. Suddath, R.L., Casanova, M.F., Goldberg, T.E., Daniel, D.G., Kelsoe, J.R. and Weinberger, D.R. (1989) Temporal lobe pathology in schizophrenia: a quantitative magnetic resonance imaging study. Am. J. Psychiatry 146, 464-472.
76. Tews, J.K., Carter, S.H., Roa, P.D. and Stone, W.E. (1963) Free amino acids and related compounds in dog brain: Postmortem and anoxic changes, effects of ammonium chloride infusion, and levels during seizures induced by picrotoxin and by pentylenetetrazol. J. Neurochem. 10, 641-653.
77. Verdoux, H., Magnin, E. and Bourgeois, M. (1995) Neuroleptic effects on neuropsychological test performance in schizophrenia. Schizophr. Res. 14, 133-139.
78. Vion-Dury, J., Meyerhoff, D.J., Cozzone, P.J. and Weiner, M.W. (1994) What might be the impact on neurology of the analysis of brain metabolism by in vivo magnetic resonance spectroscopy? J. Neurol. 241, 354-371.
79. Waddington, J.L. (1993) Schizophrenia: developmental neuroscience and pathobiology. Lancet 341, 531-536.
80. Woods, B.T., Yurgelun-Todd, D., Benes, F.M., Frankenburg, F.R., Pope, H.G. and McSparren, J. (1990) Progressive ventricular enlargement in schizophrenia: Comparison to bipolar affective disorder and correlation with clinical course. Biol. Psychiatry 27, 341-352.
81. 1H-Magnetic resonance spectroscopy (MRS) of the temporal lobes in schizophrenia. Schizophr. Res. 9, 213.
82. Zipursky, R.B., Lim, K.O., Rosenbloom, M. and Pfefferbaum, A. (1988) Differing effects of duration of illness on CT findings in alcoholism and schizophrenia. Psychopharmacol. Bull. 24, 495-500.
83. Zipursky, R.B., Lim, K.O., Sullivan, E.V., Brown, B.W. and Pfefferbaum, A. (1992) Widespread cerebral grey matter volume deficits in schizophrenia. Arch. Gen. Psychiatry 49, 195-205.